Retinoblastoma
A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)
Drugs by status
Approved for this indication (1)
Phase 4 trials (5)
Phase 3 trials (11)
Phase 2 trials (13)
Phase 1 trials (22)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (11)
- National Cancer Institute (NCI)
- Hospital JP Garrahan
- University of Michigan
- Wayne State University
- Adolphe Rothschild Ophtalmologic Foundation
- Curie Institute
- University of Barcelona
- Hospital Pereyra Rossell, Montevideo
- Hospital San Juan de Dios, Santiago
- National Cancer Institute Rio de Janeiro
- St. Jude Children's Hospital
Organization Involved with Phase 2 Indications (39)
- Eli Lilly
- Fundació Sant Joan de Déu
- Centre Leon Berard
- Cornell University
- Harvard University
- Johns Hopkins University
- New York University
- Northwestern University
- Stanford University
- University of Lausanne
- University of Toronto
- University of Bordeaux
- University of Angers
- University of Western Brittany
- Bocage University
- University of Limoges
- Jean Monnet University
- University of Strasbourg
- Children Hospital of Toulouse
- François Rabelais University
- University of Montpellier
- University of Lille
- Hebrew University
- Hospital Universitari General de Catalunya
- University of Reims
- University of Nantes
- University of Nice Sophia Antipolis
- University of Poitiers
- University of Texas, San Antonio
- Aix-University of Marseille
- +9 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (10)
- Children's Cancer and Leukaemia Group
- Seoul National University
- Thomas Jefferson University
- University of Miami
- University of Birmingham
- University of California, San Francisco
- University of Cincinnati
- All India Institute of Medical Sciences
- Oncology Service, Wills Eye Institute
- Council of Scientific and Industrial Research, India